Bentley adds another Ireland deal

November 23, 2005

NH Business Review Staff,

Bentley Pharmaceuticals made further headway into the Irish market early this week, a move that caused its stock price to jump on Monday.

The Exeter-based drug delivery company’s Irish subsidiary – Bentley Pharmaceuticals Ireland Ltd. — received approval to market generic Omeprazole in Ireland. Omeprazole treats acid-related stomach disorders.

The company’s Spanish subsidiary, Laboratorios Davur, entered into an agreement with the Irish-based Consilient Health Ltd. to distribute the drug throughout the United Kingdom. Laboratorios Belmac SA, another Bentley subsidiary in Spain will manufacture the drug.

On Monday, after the approval was announced, shares gained more than $2 to peak at $17.92 a share. — BOB SANDERS

Categories: News

More news from NHBR:

'From the Battlefield to the Boardroom' with Robert Campbell

Author, leadership coach and veteran of 27 years in the Army, Robert Campbell speaks on his 'Battlefield to Boardroom' book series and how companies can become veteran-ready

Live-work-create tech village eyed for Manchester

A tech-entrepreneur turned venture capitalist is eyeing one of the largest undeveloped tracts in Manchester for a community where tech- and startup-minded people would live and work. Freedom Village would be located on 250 acres of mostly wooded land at Hackett Hill, which is located in the northwestern corner of Manchester.

NHBR About Town: Week of October 9, 2026

Business and event happenings around the state of NH

Manchester property values jump nearly 50%

The value of all property in Manchester increased by almost half — 48% ‑ over the past five years, according to preliminary data released by city officials on Oct. 13 The valuations, compiled due to a citywide revaluation, add up to $23.09 billion. The current value of city properties is $15.56 billion, which was based on assessments made during the city's last revaluation.